DOSSIER · 13F-HR · Q1 2026

Catalio Capital Management, LP

$479M in tracked AUM across 41 positions as of Q1 2026.

CC
CIK 0001958125 · last filed Mar 31, 2026
Total AUM
$479M
as of Q1 2026
Holdings
41
positions
Whale Score
56
56
tracked
Activity
no data
changes this Q
AI Analysis · Q1 2026

Catalio Capital Management, LP filed its latest 13F-HR for Q1 2026. See the latest holdings and position changes below.

Quarter at a glance — Q1 2026

Position-change comparison pending.

No quarter-over-quarter changes available.

Top 10 holdings

By portfolio weight as of Q1 2026.

#HoldingValueSharesWeight
01
DNTH
DIANTHUS THERAPEUTICS INC
$47M560K9.8%
02
BBIO
BRIDGEBIO PHARMA INC
$32M432K6.7%
03
ASND
ASCENDIS PHARMA A/S
$30M129K6.2%
04
BMY
BRISTOL-MYERS SQUIBB CO
$26M421K5.3%
05
SNDX
SYNDAX PHARMACEUTICALS INC
$24M1.0M5.1%
06
GILD
GILEAD SCIENCES INC
$23M164K4.8%
07
TERN
TERNS PHARMACEUTICALS INC
$22M409K4.5%
08
DFTX
DEFINIUM THERAPEUTICS INC
$20M1.0M4.1%
09
SLNO
SOLENO THERAPEUTICS INC
$19M578K4.0%
10
BSX
BOSTON SCIENTIFIC CORP
$19M299K3.9%

Filing history

2026Q1Mar 31
$479M 15.4%
41 positionsView →
2025Q4Dec 31
$566M 4.6%
45 positionsView →
2025Q3Sep 30
$541M 13.4%
38 positionsView →
2025Q2Jun 30
$477M 107.4%
40 positionsLocked
2025Q1Mar 31
$230M 49.7%
24 positionsLocked
2024Q4Dec 31
$457M
33 positionsLocked